Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 24,470 | 20,053 | 11,328 | 11,372 | 9,618 |
| Depreciation Amortization | 314 | 2,433 | 2,240 | 1,692 | 933 |
| Income taxes - deferred | 175 | 90 | 1,550 | -2,667 | 456 |
| Accounts receivable | -2,547 | -4,309 | -844 | -1,263 | 391 |
| Other Working Capital | -3,539 | -5,031 | -2,088 | 5,822 | -506 |
| Other Operating Activity | 3,412 | 4,494 | 972 | 1,397 | -285 |
| Operating Cash Flow | $22,285 | $17,731 | $13,158 | $16,352 | $10,607 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -32,034 | -11,459 | -10,367 | -16,693 | -20,110 |
| Investing Cash Flow | $-32,034 | $-11,459 | $-10,367 | $-16,693 | $-20,110 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,192 | 2,571 | 396 | 711 | 2,824 |
| Common Stock Repurchased | -621 | -3,000 | -617 | -1,049 | -1,803 |
| Other Financing Activity | 0 | 0 | 0 | 303 | 3,808 |
| Financing Cash Flow | $1,571 | $-429 | $-221 | $-34 | $4,830 |
| Beginning Cash Position | 13,177 | 7,334 | 4,763 | 5,138 | 9,811 |
| End Cash Position | 4,999 | 13,177 | 7,334 | 4,763 | 5,138 |
| Net Cash Flow | $-8,177 | $5,843 | $2,570 | $-375 | $-4,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,285 | 17,731 | 13,158 | 16,352 | 10,607 |
| Free Cash Flow | 22,285 | 17,731 | 13,158 | 16,352 | 10,607 |